NRG delivers 10 patient doses of Lutetium-177
NRG delivers 10 patient doses of Lutetium-177 Last week, NRG has delivered lutetium for the first time to an academic hospital and two pharmaceutical parties this month. Sander de Groot, program manager medical isotopes at NRG: “This isotope offers a great perspective for the effective treatment of various cancer indications and with limited side effects.…